DewDiligence Wednesday, 02/05/20 08:20:57 AM Re: None Post # of 544 Spinoff of women’s health/off-patent brands/biosimilars into new (as yet unnamed) company is planned for 1H21: https://finance.yahoo.com/news/merck-focus-key-growth-pillars-114500519.html The spinoff is expected to have ~$6.5B of annual sales (~15% of existing MRK), of which 75% will be ex-US. “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”